FDA Approves Label Update for Biktarvy as Treatment of HIV in Pregnant Adults
Pharmacy Times
APRIL 26, 2024
The approval is based on data from Study 5310, evaluating the pharmacokinetics, safety, and efficacy of Biktarvy (Gilead Sciences Inc) in pregnant individuals.
Let's personalize your content